221 related articles for article (PubMed ID: 31953711)
21. [The study of mitochondrial disorder pedigree associated with FASTKD2 variants and uniparental disomy].
Ma YN; Lin LL; Zhang Y; Li L; Wu HR; Xiao Y; Pan H; Yang YL; Qi Y
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):171-177. PubMed ID: 36649987
[No Abstract] [Full Text] [Related]
22. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8
Cannons JL; Preite S; Kapnick SM; Uzel G; Schwartzberg PL
Front Immunol; 2018; 9():1758. PubMed ID: 30116245
[TBL] [Abstract][Full Text] [Related]
23. Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.
Tangye SG; Bier J; Lau A; Nguyen T; Uzel G; Deenick EK
J Clin Immunol; 2019 Feb; 39(2):148-158. PubMed ID: 30911953
[TBL] [Abstract][Full Text] [Related]
24. First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.
Zhang P; Wu B; Lu Y; Ni Q; Liu R; Zhou W; Wang H
Mol Genet Genomic Med; 2020 Mar; 8(3):e1144. PubMed ID: 31985178
[TBL] [Abstract][Full Text] [Related]
25. Maternal uniparental disomy of chromosome 2 in a patient with a DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome.
Haudry C; de Lonlay P; Malan V; Bole-Feysot C; Assouline Z; Pruvost S; Brassier A; Bonnefont JP; Munnich A; Rötig A; Lebre AS
Mol Genet Metab; 2012 Dec; 107(4):700-4. PubMed ID: 23141463
[TBL] [Abstract][Full Text] [Related]
26. Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort.
Oh J; Garabedian E; Fuleihan R; Cunningham-Rundles C
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4095-4102. PubMed ID: 34352450
[TBL] [Abstract][Full Text] [Related]
27. Activated phosphoinositide 3-dinase delta syndrome (APDS): An update.
Lougaris V; Cancrini C; Rivalta B; Castagnoli R; Giardino G; Volpi S; Leonardi L; La Torre F; Federici S; Corrente S; Cinicola BL; Soresina A; Marseglia GL; Cardinale F
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):69-72. PubMed ID: 35080319
[TBL] [Abstract][Full Text] [Related]
28. Hyperactive PI3Kδ predisposes naive T cells to activation via aerobic glycolysis programs.
Jia Y; Yang Q; Wang Y; Li W; Chen X; Xu T; Tian Z; Feng M; Zhang L; Tang W; Tian N; Zhou L; Song W; Zhao X
Cell Mol Immunol; 2021 Jul; 18(7):1783-1797. PubMed ID: 32099075
[TBL] [Abstract][Full Text] [Related]
29. PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8
Cannons JL; Villarino AV; Kapnick SM; Preite S; Shih HY; Gomez-Rodriguez J; Kaul Z; Shibata H; Reilley JM; Huang B; Handon R; McBain IT; Gossa S; Wu T; Su HC; McGavern DB; O'Shea JJ; McGuire PJ; Uzel G; Schwartzberg PL
Cell Rep; 2021 Oct; 37(2):109804. PubMed ID: 34644563
[TBL] [Abstract][Full Text] [Related]
30. Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively.
Thompson DA; McHenry CL; Li Y; Richards JE; Othman MI; Schwinger E; Vollrath D; Jacobson SG; Gal A
Am J Hum Genet; 2002 Jan; 70(1):224-9. PubMed ID: 11727200
[TBL] [Abstract][Full Text] [Related]
31. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.
Angulo I; Vadas O; Garçon F; Banham-Hall E; Plagnol V; Leahy TR; Baxendale H; Coulter T; Curtis J; Wu C; Blake-Palmer K; Perisic O; Smyth D; Maes M; Fiddler C; Juss J; Cilliers D; Markelj G; Chandra A; Farmer G; Kielkowska A; Clark J; Kracker S; Debré M; Picard C; Pellier I; Jabado N; Morris JA; Barcenas-Morales G; Fischer A; Stephens L; Hawkins P; Barrett JC; Abinun M; Clatworthy M; Durandy A; Doffinger R; Chilvers ER; Cant AJ; Kumararatne D; Okkenhaug K; Williams RL; Condliffe A; Nejentsev S
Science; 2013 Nov; 342(6160):866-71. PubMed ID: 24136356
[TBL] [Abstract][Full Text] [Related]
32. A Rare Case of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Presenting With Hemophagocytosis Complicated With Hodgkin Lymphoma.
Cansever M; Zietara N; Chiang SCC; Ozcan A; Yilmaz E; Karakukcu M; Rohlfs M; Somekh I; Canoz O; Abdulrezzak U; Bryceson Y; Klein C; Unal E; Patiroglu T
J Pediatr Hematol Oncol; 2020 Mar; 42(2):156-159. PubMed ID: 31033788
[TBL] [Abstract][Full Text] [Related]
33. Dysregulated actin dynamics in activated PI3Kδ syndrome.
Wallace JG; Zambrano-Rodas P; Córdova-Calderón W; Estrada-Turriate S; Mendoza-Quispe D; Limache Ontiveros Y; Geha RS; Chou J; Platt CD
Clin Immunol; 2020 Jan; 210():108311. PubMed ID: 31760094
[TBL] [Abstract][Full Text] [Related]
34. Paternal uniparental heterodisomy with partial isodisomy of chromosome 1 in a patient with retinitis pigmentosa without hearing loss and a missense mutation in the Usher syndrome type II gene USH2A.
Rivolta C; Berson EL; Dryja TP
Arch Ophthalmol; 2002 Nov; 120(11):1566-71. PubMed ID: 12427073
[TBL] [Abstract][Full Text] [Related]
35. Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in
Dornan GL; Siempelkamp BD; Jenkins ML; Vadas O; Lucas CL; Burke JE
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1982-1987. PubMed ID: 28167755
[TBL] [Abstract][Full Text] [Related]
36. Activated PI3K-delta syndrome in an Egyptian pediatric cohort with primary immune deficiency.
Ahmed AA; El Shahaway AA; Hussien SA
Allergol Immunopathol (Madr); 2020; 48(6):686-693. PubMed ID: 32349894
[TBL] [Abstract][Full Text] [Related]
37. Partial uniparental isodisomy of chromosome 16 unmasks a deleterious biallelic mutation in IFT140 that causes Mainzer-Saldino syndrome.
Helm BM; Willer JR; Sadeghpour A; Golzio C; Crouch E; Vergano SS; Katsanis N; Davis EE
Hum Genomics; 2017 Jul; 11(1):16. PubMed ID: 28724397
[TBL] [Abstract][Full Text] [Related]
38. Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.
Condliffe AM; Chandra A
Front Immunol; 2018; 9():338. PubMed ID: 29556229
[TBL] [Abstract][Full Text] [Related]
39. A case of early-onset epileptic encephalopathy with a homozygous TBC1D24 variant caused by uniparental isodisomy.
Nakashima M; Negishi Y; Hori I; Hattori A; Saitoh S; Saitsu H
Am J Med Genet A; 2019 Apr; 179(4):645-649. PubMed ID: 30680869
[TBL] [Abstract][Full Text] [Related]
40. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
Edwards ESJ; Bier J; Cole TS; Wong M; Hsu P; Berglund LJ; Boztug K; Lau A; Gostick E; Price DA; O'Sullivan M; Meyts I; Choo S; Gray P; Holland SM; Deenick EK; Uzel G; Tangye SG
J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
